This content is only available within our institutional offering.

29 Apr 2022
Hikma Pharmaceuticals: Q1 update after completion of CustoPharm

Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
Hikma Pharmaceuticals: Q1 update after completion of CustoPharm
Hikma Pharmaceuticals Plc (HIK:LON) | 1,835 238.6 0.7% | Mkt Cap: 4,072m
- Published:
29 Apr 2022 -
Author:
Stefan Hamill | Paul Cuddon | Kane Slutzkin -
Pages:
4 -